The global cryptocurrency market capitalization has crested $3.18 trillion on December 12, 2025—a 2.82% daily decline from peaks—yet up 3.2%...

December 2025's cryptocurrency currents churn with consolidation and controversy: Ethereum (ETH) clings above $3,100 amid ETF outflows and network upgrades,...

Ethereum (ETH) has steadfastly held above $3,100 as of December 12, 2025, trading at $3,346.65—a 0.014% daily uptick—defying a 2.25%...

ChatGPT forecasts Bitcoin (BTC) at $100,000 by December 31, 2025—a conservative cycle cap amid $92,000 trades—per Finbold's February 28 query,...

Human photosynthesis dawns: March 2025 preprints hypothesize Ice Age adaptations via symbiotic cyanobacteria phagocytosis, engineering skin-embedded chloroplasts for 10-20% caloric...

Neuroscience's boldest feat: October 2025 eLife trials graft hippocampal engrams—optogenetically tagged fear memories—from donor to recipient mice, yielding 80% recall...

LK-99's phoenix rises: January 2025 replications by Quantum Energy Research Centre confirm room-temperature (127°C), ambient-pressure superconductivity in purified lead-apatite variants,...

Nuclear fusion's holy grail glimmers brighter: Lawrence Livermore National Laboratory's (LLNL) June 22, 2025, ignition yields a record 413% net...

Kyoto University Hospital's September 2025 launch of the world's first human trial for tooth-regrowth drug TRG035—targeting USAG-1 inhibition—ushers regenerative dentistry's...

The FDA's December 2025 approval of deuruxolitinib (Leqselvi®) as a first-line oral therapy for moderate-to-severe alopecia areata (AA) in adults...